489 results on '"Gremmel, Thomas"'
Search Results
2. Three Cases of Tickborne Francisella tularensis Infection, Austria, 2022
3. Omission of Antiplatelet Therapy in Patients With HeartMate 3 Left Ventricular Assist Devices: A Systematic Review and Meta-Analysis
4. Platelet reactivity is associated with pump thrombosis in patients with left ventricular assist devices
5. Anticoagulation in atrial fibrillation and end-stage kidney disease on hemodialysis: a meta-analysis of randomized trials comparing direct oral anticoagulants with vitamin K antagonists
6. Reticulated platelets in cirrhosis – Just a surrogate for thrombocytopenia?
7. Platelet Physiology
8. Microvascular rarefaction in patients with cerebrovascular events
9. Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Coronary Syndrome: Implications for Platelet Reactivity?
10. Sex-specific platelet activation through protease-activated receptor-1 in patients undergoing cardiac catheterization
11. Reply: ‘Letter to the editor: Are we comparing apples with oranges?’
12. Residual platelet reactivity in low-dose aspirin-treated patients with class 1 obesity
13. Decreased Platelet Inhibition by Thienopyridines in Hyperuricemia
14. Sublingual microvasculature in diabetic patients
15. Decreased platelet activation predicts hepatic decompensation and mortality in patients with cirrhosis
16. Ticagrelor Inhibits Toll-Like and Protease-Activated Receptor Mediated Platelet Activation in Acute Coronary Syndromes
17. Protease‐activated receptor‐mediated platelet aggregation in acute coronary syndrome patients on potent P2Y12 inhibitors
18. Response to aspirin therapy in patients with myeloproliferative neoplasms depends on the platelet count
19. Micro- and Macrovascular Effects of Inflammation in Peripheral Artery Disease—Pathophysiology and Translational Therapeutic Approaches
20. Cardiovascular events in patients treated with bempedoic acid versus placebo: systematic review and meta-analysis
21. Toll-like Receptors as Pro-Thrombotic Drivers in Viral Infections: A Narrative Review
22. Novel aspects of antiplatelet therapy in cardiovascular disease
23. Circulating microRNAs identify patients at increased risk of in-stent restenosis after peripheral angioplasty with stent implantation
24. Non-vitamin K antagonist oral anticoagulants in patients with an increased risk of bleeding
25. Decreased platelet function is an independent predictor of liver-related and all-cause mortality in patients with advanced chronic liver disease
26. Oral antiplatelet agents in cardiovascular disease
27. α-Hydroxybutyrate dehydrogenase is associated with atherothrombotic events following infrainguinal angioplasty and stenting
28. Platelet Function Decreases with Increasing Severity of Liver Cirrhosis and Portal Hypertension—A Prospective Study.
29. Contributors
30. Laboratory Monitoring of Antiplatelet Therapy
31. Growth Differentiation Factor 15 Is Associated with Platelet Reactivity in Patients with Acute Coronary Syndrome
32. Microvascular Thrombosis as a Critical Factor in Severe COVID-19
33. New highly active antiplatelet agents with dual specificity for platelet P2Y1 and P2Y12 adenosine diphosphate receptors
34. Sublingual functional capillary rarefaction in chronic heart failure
35. Decreased platelet inhibition by P2Y12 receptor blockers in anaemia
36. Functional capillary impairment in patients with ventricular assist devices
37. Antiplatelet Therapy in Coronary Artery Disease: Now and Then
38. Impact of ABO Blood Group on Thromboembolic and Bleeding Complications in Patients with Left Ventricular Assist Devices
39. Impact of body size on platelet function in patients with acute coronary syndrome on dual antiplatelet therapy
40. Disaggregation Following Agonist-Induced Platelet Activation in Patients on Dual Antiplatelet Therapy
41. Microparticle-associated tissue factor activity in patients with acute unprovoked deep vein thrombosis and during the course of one year
42. Thrombin-induced platelet activation across distinct stages of portal hyperension and cirrhosis
43. Human neutrophil α-defensins are associated with adenosine diphosphate-inducible neutrophil-platelet aggregate formation and response to clopidogrel in patients with atherosclerosis
44. Antiplatelet Therapy in Coronary Artery Disease: Now and Then.
45. Impaired glucose metabolism is associated with increased thrombin generation potential in patients undergoing angioplasty and stenting
46. Protease‐activated receptor‐mediated platelet aggregation in patients with type 2 diabetes on potent P2Y 12 inhibitors
47. Growth Differentiation Factor-15 Correlates Inversely with Protease-Activated Receptor-1-Mediated Platelet Reactivity in Patients with Left Ventricular Assist Devices
48. Residual platelet activation through protease-activated receptors (PAR)-1 and ‐4 in patients on P2Y12 inhibitors
49. Response to antiplatelet therapy is independent of endogenous thrombin generation potential
50. Obesity is associated with poor response to clopidogrel and an increased susceptibility to protease activated receptor-1 mediated platelet activation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.